Oppenheimer & CO Inc Abbott Laboratories Transaction History

Oppenheimer & CO Inc

  • $6.18 Billion
  • Q2 2024

A detailed history of Oppenheimer & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Oppenheimer & CO Inc holds 100,109 shares of ABT stock, worth $11.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
100,109
Previous 96,365 3.89%
Holding current value
$11.3 Million
Previous $11 Million 5.02%
% of portfolio
0.17%
Previous 0.19%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$100.73 - $112.44 $377,133 - $420,975
3,744 Added 3.89%
100,109 $10.4 Million
Q1 2024

May 06, 2024
SELL
$109.52 - $120.96 $748,459 - $826,640
-6,834 Reduced 6.62%
96,365 $11 Million
Q4 2023

Feb 13, 2024
SELL
$90.19 - $110.4 $310,433 - $379,996
-3,442 Reduced 3.23%
103,199 $11.4 Million
Q3 2023

Nov 07, 2023
BUY
$95.53 - $114.62 $669,951 - $803,830
7,013 Added 7.04%
106,641 $10.3 Million
Q2 2023

Aug 02, 2023
SELL
$100.78 - $112.29 $122,044 - $135,983
-1,211 Reduced 1.2%
99,628 $10.9 Million
Q1 2023

May 10, 2023
BUY
$96.86 - $114.01 $548,227 - $645,296
5,660 Added 5.95%
100,839 $10.2 Million
Q4 2022

Feb 07, 2023
BUY
$95.06 - $111.52 $27,662 - $32,452
291 Added 0.31%
95,179 $10.5 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $97,727 - $113,150
1,010 Added 1.08%
94,888 $9.18 Million
Q2 2022

Aug 08, 2022
BUY
$102.07 - $123.37 $779,406 - $942,053
7,636 Added 8.85%
93,878 $10.2 Million
Q1 2022

May 12, 2022
BUY
$114.02 - $139.04 $521,413 - $635,829
4,573 Added 5.6%
86,242 $10.2 Million
Q4 2021

Feb 02, 2022
SELL
$115.53 - $141.46 $18,831 - $23,057
-163 Reduced 0.2%
81,669 $11.5 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $109,427 - $121,058
938 Added 1.16%
81,832 $9.67 Million
Q2 2021

Aug 03, 2021
SELL
$105.79 - $124.53 $407,185 - $479,315
-3,849 Reduced 4.54%
80,894 $9.38 Million
Q1 2021

May 10, 2021
SELL
$108.84 - $128.23 $469,753 - $553,440
-4,316 Reduced 4.85%
84,743 $10.2 Million
Q4 2020

Feb 11, 2021
SELL
$105.0 - $114.42 $77,175 - $84,098
-735 Reduced 0.82%
89,059 $9.75 Million
Q3 2020

Nov 13, 2020
SELL
$91.64 - $111.29 $2.57 Million - $3.12 Million
-28,014 Reduced 23.78%
89,794 $9.77 Million
Q2 2020

Aug 11, 2020
BUY
$76.57 - $98.0 $38,131 - $48,804
498 Added 0.42%
117,808 $10.8 Million
Q1 2020

May 08, 2020
BUY
$62.82 - $91.86 $98,627 - $144,220
1,570 Added 1.36%
117,310 $9.26 Million
Q4 2019

Feb 07, 2020
BUY
$78.51 - $87.4 $543,603 - $605,157
6,924 Added 6.36%
115,740 $10.1 Million
Q3 2019

Oct 31, 2019
BUY
$81.84 - $88.74 $240,609 - $260,895
2,940 Added 2.78%
108,816 $9.11 Million
Q2 2019

Aug 09, 2019
SELL
$72.88 - $85.0 $306,970 - $358,020
-4,212 Reduced 3.83%
105,876 $8.91 Million
Q1 2019

Apr 24, 2019
BUY
$66.22 - $80.06 $164,225 - $198,548
2,480 Added 2.3%
110,088 $8.8 Million
Q4 2018

Jan 29, 2019
SELL
$65.56 - $74.27 $306,689 - $347,435
-4,678 Reduced 4.17%
107,608 $7.78 Million
Q3 2018

Oct 26, 2018
BUY
$60.81 - $73.36 $373,130 - $450,136
6,136 Added 5.78%
112,286 $8.24 Million
Q2 2018

Aug 10, 2018
SELL
$57.57 - $63.54 $1.25 Million - $1.38 Million
-21,669 Reduced 16.95%
106,150 $6.48 Million
Q1 2018

May 01, 2018
SELL
$56.27 - $63.62 $710,352 - $803,138
-12,624 Reduced 8.99%
127,819 $7.66 Million
Q4 2017

Feb 07, 2018
BUY
$53.68 - $57.47 $743,092 - $795,557
13,843 Added 10.93%
140,443 $8.02 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $6.08 Million - $6.79 Million
126,600
126,600 $6.76 Million

Others Institutions Holding ABT

# of Institutions
3,135
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email